OrganiGram Holdings Inc. (OGI.TO)
CAD 1.45
(4.32%)
CAD 1.45
(4.32%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 79 Thousand CAD | -96.65% |
| 2022 | 2.36 Million CAD | -51.63% |
| 2021 | 4.88 Million CAD | -95.29% |
| 2020 | 103.67 Million CAD | 125.04% |
| 2019 | 46.06 Million CAD | -53.35% |
| 2018 | 98.74 Million CAD | 3056.25% |
| 2017 | 3.12 Million CAD | -56.31% |
| 2016 | 7.16 Million CAD | 56.55% |
| 2015 | 4.57 Million CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 39 Thousand CAD | -25.0% |
| 2024 Q1 | 65 Thousand CAD | -17.72% |
| 2024 Q2 | 52 Thousand CAD | -20.0% |
| 2023 Q4 | 79 Thousand CAD | -21.0% |
| 2023 Q1 | 137 Thousand CAD | -94.2% |
| 2023 Q2 | 118 Thousand CAD | -13.87% |
| 2023 Q3 | 100 Thousand CAD | -15.25% |
| 2023 FY | 79 Thousand CAD | -96.65% |
| 2022 Q2 | 2.87 Million CAD | -6.57% |
| 2022 Q4 | 2.36 Million CAD | -9.78% |
| 2022 FY | 2.36 Million CAD | -51.63% |
| 2022 Q1 | 3.07 Million CAD | -37.02% |
| 2022 Q3 | 2.61 Million CAD | -8.88% |
| 2021 Q2 | 52.75 Million CAD | -8.88% |
| 2021 Q3 | 5.14 Million CAD | -90.24% |
| 2021 FY | 4.88 Million CAD | -95.29% |
| 2021 Q4 | 4.88 Million CAD | -5.19% |
| 2021 Q1 | 57.9 Million CAD | -44.15% |
| 2020 FY | 103.67 Million CAD | 125.04% |
| 2020 Q3 | 81.64 Million CAD | 3840.15% |
| 2020 Q2 | 2.07 Million CAD | -97.42% |
| 2020 Q1 | 80.27 Million CAD | 74.27% |
| 2020 Q4 | 103.67 Million CAD | 26.99% |
| 2019 Q4 | 46.06 Million CAD | -2.39% |
| 2019 FY | 46.06 Million CAD | -53.35% |
| 2019 Q3 | 47.19 Million CAD | 329.21% |
| 2019 Q2 | 10.99 Million CAD | -88.81% |
| 2019 Q1 | 98.29 Million CAD | -0.45% |
| 2018 Q4 | 98.74 Million CAD | 0.48% |
| 2018 FY | 98.74 Million CAD | 3056.25% |
| 2018 Q1 | 3.01 Million CAD | -3.52% |
| 2018 Q2 | 95.88 Million CAD | 3076.83% |
| 2018 Q3 | 98.26 Million CAD | 2.48% |
| 2017 Q2 | 3.28 Million CAD | -3.37% |
| 2017 Q1 | 3.39 Million CAD | -52.55% |
| 2017 FY | 3.12 Million CAD | -56.31% |
| 2017 Q4 | 3.12 Million CAD | -2.23% |
| 2017 Q3 | 3.19 Million CAD | -2.54% |
| 2016 Q4 | 7.16 Million CAD | -1.15% |
| 2016 Q3 | 7.24 Million CAD | -1.14% |
| 2016 Q2 | 7.32 Million CAD | 3.08% |
| 2016 Q1 | 7.1 Million CAD | 55.41% |
| 2016 FY | 7.16 Million CAD | 56.55% |
| 2015 FY | 4.57 Million CAD | 0.0% |
| 2015 Q4 | 4.57 Million CAD | 107.02% |
| 2015 Q3 | 2.2 Million CAD | -1.98% |
| 2015 Q2 | 2.25 Million CAD | -1.41% |
| 2015 Q1 | 2.28 Million CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | 47.57 Million CAD | 99.834% |
| Avicanna Inc. | 95.36 Thousand CAD | 17.158% |
| Avant Brands Inc. | 1.74 Million CAD | 95.462% |
| Cardiol Therapeutics Inc. | 158.53 Thousand CAD | 50.168% |
| Crescita Therapeutics Inc. | 815 Thousand CAD | 90.307% |
| Knight Therapeutics Inc. | 44.01 Million CAD | 99.821% |
| MediPharm Labs Corp. | 69 Thousand CAD | -14.493% |
| Canopy Growth Corporation | 493.29 Million CAD | 99.984% |
| Willow Biosciences Inc. | 594 Thousand CAD | 86.7% |
| Auxly Cannabis Group Inc. | 81.38 Million CAD | 99.903% |